


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 24 Apr 2008
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
HSMN NewsFeed - 21 Apr 2008
Pfizer Japan Receives Manufacturing and Marketing Authorization for SUTENT
Pfizer Japan Receives Manufacturing and Marketing Authorization for SUTENT
HSMN NewsFeed - 21 Apr 2008
Cerus Receives Label Expansion on CE Marks for Use of INTERCEPT Blood System
Cerus Receives Label Expansion on CE Marks for Use of INTERCEPT Blood System
HSMN NewsFeed - 17 Apr 2008
Medtronic Announces CE Mark and European Launch of New 'Defender' Embolic Protection Filter
Medtronic Announces CE Mark and European Launch of New 'Defender' Embolic Protection Filter
HSMN NewsFeed - 17 Apr 2008
Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
HSMN NewsFeed - 16 Apr 2008
European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009
European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009
HSMN NewsFeed - 16 Apr 2008
Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
HSMN NewsFeed - 15 Apr 2008
Onset Medical Receives CE Mark Clearance to Market SoloPath(TM) Percutaneous Transseptal Access Catheter
Onset Medical Receives CE Mark Clearance to Market SoloPath(TM) Percutaneous Transseptal Access Catheter
HSMN NewsFeed - 14 Apr 2008
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
HSMN NewsFeed - 9 Apr 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
HSMN NewsFeed - 8 Apr 2008
Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
HSMN NewsFeed - 7 Apr 2008
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
HSMN NewsFeed - 7 Apr 2008
New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
HSMN NewsFeed - 1 Apr 2008
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval
HSMN NewsFeed - 31 Mar 2008
Cerus Appoints Carol M. Moore as Vice President, Regulatory Affairs and Quality
Cerus Appoints Carol M. Moore as Vice President, Regulatory Affairs and Quality
HSMN NewsFeed - 27 Mar 2008
Abiomed Receives European CE Mark Approval for AB5000(R) Portable Circulatory Support Driver
Abiomed Receives European CE Mark Approval for AB5000(R) Portable Circulatory Support Driver
HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
HSMN NewsFeed - 26 Mar 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
BioAlliance Pharma Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
HSMN NewsFeed - 25 Mar 2008
Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System
Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System
HSMN NewsFeed - 24 Mar 2008
SJTRI Coronary Stent Research Leads to CE Mark Approval for Bare Metal Stent
SJTRI Coronary Stent Research Leads to CE Mark Approval for Bare Metal Stent
HSMN NewsFeed - 20 Mar 2008
CHMP Upholds Negative Opinion for the EU Application for Cimzia(R) in the Treatment of Crohn's Disease
CHMP Upholds Negative Opinion for the EU Application for Cimzia(R) in the Treatment of Crohn's Disease
HSMN NewsFeed - 20 Mar 2008
Pharming to receive Negative Opinion on European Marketing Authorization Application for Rhucin(R)
Pharming to receive Negative Opinion on European Marketing Authorization Application for Rhucin(R)
HSMN NewsFeed - 19 Mar 2008
Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients
Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients
HSMN NewsFeed - 19 Mar 2008
Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
HSMN NewsFeed - 12 Mar 2008
iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
HSMN NewsFeed - 10 Mar 2008
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
HSMN NewsFeed - 6 Mar 2008
InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs
InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs
